Pacilarium Paclitaxel Injection 300 mg is a prescription oncology medicine identified as containing Paclitaxel 300 mg.

Paclitaxel belongs to the taxane class of cytotoxic antineoplastic medicines.

It stabilizes microtubules and interferes with normal cell division, contributing to the destruction of susceptible cancer cells.

Paclitaxel is an established component of selected chemotherapy regimens for breast cancer, ovarian cancer, non-small cell lung cancer and other malignancies.

It may be administered alone or in combination with other anticancer medicines, depending on the diagnosis and prescribed oncology protocol.

The stated 300 mg strength does not establish the vial volume, concentration, formulation or individual patient dose.

The exact formulation of Pacilarium must be verified because conventional solvent-based paclitaxel and albumin-bound paclitaxel have different preparation, dosing and administration requirements.

The exact manufacturer, packaging and approved indications of Pacilarium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Pacilarium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features